Ierachmiel Daskal wrote: >I ( we the Blood banking Community) need your help: > >The American Association of Blood Banking and the FDA will try and >implement by 03/01/04 a set of new regulations concerning the >determination whether bags of random human platelets are contaminated >with bacteria. Every hospital in the US will be required to assay >every unit of platelets prior to transfusion to determine if there is a >bacterial contamination present. > >This is an enormous task since to date, there is no reliable >methodology ( pH dip sticks, glucose levels, Gram stain...) to >determine the bacterial contaminations in the sterile bags received from >te Red Cross. The method must be a rapid one since the overall shelf >life of platelets is 5 days only and hence the units cannot be >quarantined for long time prior to release to patients. > >The question to the Flow Community is whether some flow technology can >be applied to determine if such contamination is present in a specimen >obtained in a sterile manner form the unit to be transfused to >patients.. >For example are there any "pan-bacterial wall" antibodies available that >one use , to check a sample from a bag of platelets to determine the >extent of contamination if any. The major contaminants that we will be >dealing will be skin flora ( ie Staph. epi. from the donor's skin and >Gram negative rods). Question number one: what level of contamination are you expected to be able to detect? The maximum sample (i.e., core) flow rate in a flow cytometer is typically 1.5 uL/second. Sampling 1 mL of platelet concentrate (an amount not likely to be missed from a 150 mL transfer bag), even if you ran it essentially undiluted, would take you about 11 minutes. Assuming you had some robust combination of parameters that could reliably detect bacteria and discriminate them from platelets and from any residual red cells and leukocytes, you'd be likely to miss one or two organisms; also, if the average number of organisms in 1 mL is one or two, Poisson statistics tells us that a substantial fraction of 1 mL samples will contain no organisms. You'd probably notice a few dozen organisms/mL and almost definitely catch 100 or more. Of course, it is unlikely that you will be able to run undiluted platelets in a flow cytometer; if you dilute them even 1:10, it will take you close to 2 hours to look at a single 1 mL sample. And maybe you want to detect bacteria at the same level a blood culture would; a typical blood culture inoculation volume is 10 mL, and the culture can show up positive after incubation if there is only a single viable organism in the original 10 mL inoculum. If you needed to detect that level of contamination without incubation, it would take most of a day to look at a single specimen. So, flow cytometry on the raw specimen is impractical, even if you've got an ideal set of reagents. You will have to concentrate and/or incubate a few mL of sample to find what you're looking for. Some combination of fluorescent indicators of nucleic acid content (e.g., the various SYTO dyes from Molecular Probes) and of metabolism (fluorogenic enzyme substrates, membrane potential probes) will give you fairly strong signals and good discrimination; although some people have suggested using either antibodies or various lectins to detect bacteria, the general applicability of these procedures is far from proven, and the signals from fluorescent antibodies and lectins will not be as strong as those from nucleic acid dyes and metabolic indicators. It will almost certainly be necessary to use detergent or other chemical treatment to get rid of most of the platelet mass in order to analyze the sample by flow cytometry; once you do that, it is probably just as easy to run the sample through a small-pore black membrane or aluminum oxide filter and look for bacteria using a fluorescence microscope or an image analyzer. Fluorescence miocroscopes are about to get a lot less expensive with the introduction of LED light sources that can effectively replace xenon and mercury arc and quartz halogen lamps for most applications, and inexpensive image analyzers with LED light sources and CCD detectors, more than up to the task, should be available as laboratory instruments (but probably not with FDA clearance as clinical devices) in a year or so. I hope to have a lot more to say about this in print in the next few months. For what it's worth, I recall that the folks at Biometric Imaging were looking into detection of bacteria in platelet concentrates on their IMAGN 2000 around the time that company was acquired by Becton-Dickinson. I keep hearing that the IMAGN 2000, which was unceremoniously yanked from the market some years back despite having acquired a following among blood bankers, is being resurrected, but I haven't been able to get details from anybody at BD. If they don't get it out soon, its job will be taken by a much cheaper, simpler, instrument. I'd be happy to provide more details. -HowardReceived on Tue Feb 10 16:58:00 2004
This archive was generated by hypermail 2.1.8 : Wed Feb 11 2004 - 03:12:02 EST